SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 68.59 |
| Enterprise Value ($M) | 28.24 |
| Book Value ($M) | 37.09 |
| Book Value / Share | 0.76 |
| Price / Book | 1.85 |
| NCAV ($M) | 27.01 |
| NCAV / Share | 0.56 |
| Price / NCAV | 2.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.98 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.92 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.01 |
| Current Ratio | 3.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 51.45 |
| Assets | 61.53 |
| Liabilities | 24.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.49 |
| Operating Income | -51.99 |
| Net Income | -50.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -39.96 |
| Cash from Investing | 25.00 |
| Cash from Financing | 11.86 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bleichroeder LP | 6.11 | ||
| 13G | BlackRock Inc. | 4.98 | -3.88 | |
| 13D | Marlett Christopher A | 68.20 | 1,288.62 | |
| 13D | Digiandomenico Anthony | 22.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| stifelSti UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 70,536 | 40,671 | 173.43 | |
| 28,308 | 58,542 | 48.36 | |
| 139,854 | 71,672 | 195.13 | |
| 28,824 | 42,907 | 67.18 | |
| 37,621 | 52,939 | 71.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRVO – CervoMed Inc. | CSBR – Champions Oncology, Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io